| Filed On | Filing |
|---|---|
| 21 May 2024 |
8-K/A: Financial Statements and Exhibits
[***] Certain information in this exhibit has been omitted because it is permitted to be omitted by applicable regulatory guidance. |
| 13 Nov 2023 |
8-K/A: Financial Statements and Exhibits
The unaudited condensed consolidated financial statements of Surface as of and for the six months ended June 30, 2023 and 2022 and the related notes to the consolidated financial statements are filed as Exhibit 99.1 to this Current Repor... |
| 06 Nov 2023 |
8-K/A: Financial Statements and Exhibits
To the Board of Directors and Stockholders of Surface Oncology, Inc. |
| 06 Oct 2022 |
8-K/A: Submission of Matters to a Vote of Security Holders
On May 20, 2022, Coherus BioSciences, Inc. (the “Company”) filed a Current Report on Form 8-K (the “Original Report”) disclosing the results of voting at the Company’s 2022 Annual Meeting of Stockholders (the “Annual Meeting”) held on Ma... |
| 03 Jun 2016 | 8-K/A: Entry into a Material Definitive Agreement; Other Events |
Loading...
